Yonhap Infomax News6d ago
Lotte Biologics secures CDMO contract with Japan-based global pharmaceutical firm for anticancer drug development and production, aiming to strengthen its competitive position in global biopharmaceutical markets including Japan through enhanced collaborative partnerships.
#YonhapInfomax #LotteBiologics #CDMO #AnticancerDrug #GlobalPharmaceutical #BiopharmaceuticalDevelopment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=113881
Lotte Biologics Signs CDMO Deal with Japan-Based Global Pharma for Cancer Drug

Lotte Biologics secures CDMO contract with Japan-based global pharmaceutical firm for anticancer drug development and production, aiming to strengthen its competitive position in global biopharmaceutical markets including Japan through enhanced collaborative partnerships.

Yonhap Infomax
The Times Of Central Asia | Eurasian Publication & News OnlineMar 12, 2025

Kazakhstan Cancer Drug Could Hit the Market This Year

https://fed.brid.gy/r/https://timesca.com/kazakhstan-cancer-drug-could-hit-the-market-this-year/

Kazakhstan Cancer Drug Could Hit the Market This Year - The Times Of Central Asia

Kazakhstan’s Minister of Science and Higher Education, Sayasat Nurbek, has announced the development of a domestic anti-cancer drug currently undergoing

The Times Of Central Asia